Recent Finacing
Recent Raise
O2 RegenTech develops OXAID™, a proprietary oxygenating wound dressing for chronic wounds that supplies oxygen, maintains moisture, and provides bacterial protection; patents licensed from the University of Akron.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors